Logo

Merck Licenses CRISPR Gene-Editing Technology to Evotec

DARMSTADT, Germany, Nov. 13, 2019 /PRNewswire/ -- -- License to accelerate research, enable testing and development of new drugsMerck ( https://c212.net/c/link/?t=0&l=en&o=2637501-1&h=1533565749&u=https%3A%2F%2Fwww.merckgroup.com%2F&a=Merck ), a leading science and technology company, today a...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660